Nanoparticle relieved symptoms of inflammatory bowel disease in mice

Posted by: | August 22, 2019 | Comments

Nanoparticle relieved symptoms of inflammatory bowel disease in mice

ANN ARBOR—Researchers at the University of Michigan College of Pharmacy have developed a nanoparticle that alters the gut microbiome and alleviates symptoms of inflammatory bowel disease in mice more effectively than common FDA-approved medications.

The gut microbiome––the body’s environment of healthy and unhealthy bacteria––is the next frontier for drug development, and an imbalanced gut microbiome has been implicated in many human diseases, including IBD, said James Moon, the John G. Searle Associate Professor of Pharmacy. Moon, who also has an appointment in biomedical engineering, is the principal investigator on a study that appears Aug. 19 in Nature Materials.

Read more at University of Michigan News






Stay up-to-date!
Email Address *
First Name
Last Name

* indicates required
Privacy Policy




Terms & Conditions | Privacy Policy | © 2019 The Translational Microbiome Research Forum